Newborn screening for spinal muscular atrophy in Japan: One year of experience.
Newborn screening for spinal muscular atrophy in Japan: One year of experience.
复制标题
DOI:
10.1016/j.ymgmr.2022.100908
复制
发表时间:
2022-09
影响因子:
1.9
通讯作者:
Nakamura, Kimitoshi
中科院分区:
文献类型:
--
作者:
Sawada, Takaaki;Kido, Jun;Sugawara, Keishin;Yoshida, Shinichiro;Ozasa, Shiro;Nomura, Keiko;Okada, Kentaro;Fujiyama, Natsumi;Nakamura, Kimitoshi
Spinal muscular atrophy (SMA) is a degenerative neuromuscular disease that causes progressive muscle weakness and atrophy due to loss of the anterior horn cells of the spinal cord. Although effective treatments, such as gene therapy, have emerged in recent years, their therapeutic efficacy depends on a restricted time window of treatment initiation. For the treatment to be effective, it must be started before symptoms of the disease emerge. For this purpose, newborn screening (NBS) for SMA is conducted in many countries worldwide. The NBS program for SMA has been initiated in Japan in several regions, including the Kumamoto Prefecture. We started the NBS program in February 2021 and detected a patient with SMA after screening 13,587 newborns in the first year. Herein, we report our experience with the NBS program for SMA and discuss an issue to be approached in the future.
登录
查看更多内容
影响因子:
64.5
作者:
LEFEBVRE, S;BURGLEN, L;MELKI, J
通讯作者:
MELKI, J
影响因子:
4.6
作者:
Boemer F;Caberg JH;Beckers P;Dideberg V;di Fiore S;Bours V;Marie S;Dewulf J;Marcelis L;Deconinck N;Daron A;Blasco-Perez L;Tizzano E;Hiligsmann M;Lombet J;Pereira T;Lopez-Granados L;Shalchian-Tehran S;van Assche V;Willems A;Huybrechts S;Mast B;van Olden R;Dangouloff T;Servais L
通讯作者:
Servais L
影响因子:
3.4
作者:
Harada, Yohei;Rao, Vamshi K.;Veerapandiyan, Aravindhan
通讯作者:
Veerapandiyan, Aravindhan
影响因子:
3.3
作者:
Vill, Katharina;Koelbel, Heike;Mueller-Felber, Wolfgang
通讯作者:
Mueller-Felber, Wolfgang
影响因子:
2.8
作者:
De Vivo, Darryl C.;Bertini, Enrico;Farwell, Wildon
通讯作者:
Farwell, Wildon